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Objective: Desmoid tumors are rare benign neoplasms of ﬁbroblastic origin, frequently
presenting in the abdomen of adult patients. Little is reported about clinical features
and outcome of desmoid tumors appearing in infants and children, especially when they
are located in the face. Methods: We report a girl with a desmoid tumor of her cheek,
which was present at birth. Results: The tumor was treated by surgical excision, with no
additional treatment, other than follow-up. No recurrence of the tumor was witnessed
15monthsfollowingsurgicalexcision.Summary:Radicalsurgicaltreatmentwithtumor
excision, sometimes accompanied by radiotherapy, is the current standard therapy for
infantile desmoid tumors. Pharmacological treatment may be added in selected cases.
These modalities may be challenging when desmoid tumors appear in the face because
of risks of facial distortion and associated growth problems.
Desmoid tumors are benign ﬁbrous neoplasms arising from the musculoaponeurotic
structures throughout the body. This overgrowth of ﬁbrous tissue is typically inﬁltrative,
well-deﬁned, and ﬁrm. Desmoid tumors are locally aggressive but lack the potential to
metastasize.1 An aggressive clinical behavior with tendency for recurrence makes the
treatment of these rare ﬁbrous tumors challenging. Local recurrence rates after excision
were reported to be as high as 70%.2 Complete surgical excision of desmoid tumors is
believed to be the only effective method of cure by most authors.1
Common anatomic sites for appearance of desmoid tumors include extremities, ab-
dominal wall, and mesentery. Desmoid tumors in the head and neck are uncommon in all
age groups.
Infantileaggressiveﬁbromatosisrepresentsthechildhoodformofthemusculoaponeu-
rotic ﬁbromatosis in adults.2 It arises as a solitary mass in skeletal muscle, adjacent fascia,
or periosteum. Microscopically it exists in two forms: diffuse (mesenchymal) and desmoid.
The less common desmoid form rarely occurs in infancy and even more rarely in the face.
Little has been reported in the literature about the clinical features, the treatment, and the
outcome of these lesions.
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In this article, we report an infant girl with a desmoid tumor in the deep layers of her
cheek. The clinical and imaging ﬁndings are followed by a histopathological description of
the tumor.
CASE REPORT
A 3-month-old girl with a history of a solid, immobile mass in her right cheek pre-
sented to our clinic. The lesion was present at birth and did not change dramatically
in the ﬁrst 3 months of life. The mass was ﬁrm on palpation, well-deﬁned, and mobile
(Fig 1).
Magnetic resonance imaging (MRI) study performed at this age demonstrated a hy-
perintense ﬁbrotic mass in the subcutaneous layers of the right cheek, penetrating to the
upper lip (Fig 2).
An incisional biopsy from the mass was performed. The histopathologic examination
was nondiagnostic but was suspicious for a rhabdomyomatous mesenchymal hamartoma.
With this working diagnosis, the patient was followed closely with a view to excision at a
later age.
An additional MRI study performed, when the girl was 17 months old, demonstrated
the same mass, which did not change in size or appearance from the previous MRI.
At this stage, a wide surgical excision of the mass was performed using the Weber-
Fergusson approach. The skin above the mass was spared.
The gross pathological examination of the specimen revealed a solid, gray, ill-deﬁned
massmeasuring0.8×0.9×1.3cm3.Microscopically,thelesionconsistedofsubcutaneous
fat and muscle with an inﬁltrative process composed of haphazardly arranged bland spindle
cells on a collagenous background, invading adjacent muscle ﬁbers, and focally reaching
thecauterizedsurgicalmargin.Therewasnonecrosis,andnomitoticﬁgureswereobserved.
The immunohistochemical stain for β-catenin was positive in several nuclei. Focally, cells
were also positive for α-actin. A desmin immunostain was negative. The ﬁndings were
compatible with desmoid-type ﬁbromatosis.
The previous biopsy was reexamined, and the histopathological analysis was found to
be compatible with an invading edge of ﬁbromatosis (Fig 3).
The patient had no family history of Gardner syndrome or familial adenomatous
polyposis. The patient was presented to the pediatric oncology tumor board. Because of
the young age and the problematic location of the tumor, close clinical and radiolog-
ical follow-up was recommended. A decision was made to avoid postoperative radio-




Desmoid tumors are histologically benign, ﬁbrous neoplasms originating from the mus-
culoaponeurotic structures of the body. They often appear as inﬁltrative, usually well-
differentiated, ﬁrm overgrowths of ﬁbrous tissue and tend to be aggressive locally.
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Figure 1. A 3-month-old girl with a solid, immobile mass in her right cheek. The lesion was
present at birth and did not change dramatically in the ﬁrst 3 months of life. The mass was ﬁrm
on palpation, well-deﬁned, and immobile (tumor is pointed out with an arrowhead).
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Figure 2. Magnetic resonance imaging study performed at the age of 3 months. A hyperin-
tense ﬁbrotic mass in the subcutaneous layers of the right cheek, penetrating to the upper lip is
demonstrated (arrowhead).
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Figure 3. Histopathologic ﬁndings in desmoid type ﬁbromatosis. (a) Preoperative biopsy
specimen shows a mixture of adipose tissue and skeletal muscle inﬁltrated by collagen
and bland round to spindle cells (hematoxylin and eosin, original magniﬁcation × 100).
Findings from the surgical specimen (b-d). (b) Low-power magniﬁcation shows a spindle
cell process inﬁltrating skeletal muscle (bottom left) and reaching the blue-inked surgical
margin (top right) (hematoxylin and eosin, original magniﬁcation × 50). (c) High-power
magniﬁcation shows a haphazardly arranged collagen bundles and spindle cells with round
to oval nuclei. No mitotic ﬁgures and no necrosis seen (hematoxylin and eosin, original
magniﬁcation×200).(d)β-Cateninimmunostainshowsdiffuselypositivestainingintumor
nuclei (immunoperoxidase, original magniﬁcation × 200).
Desmoid tumors are common in patients with familial adenomatous polyposis, an
autosomal inherited disease caused by a genetic mutation in the APC (adenomatous poly-
posis coli) tumor suppressor gene, which is known to be a tumor suppressor gene. Desmoid
tumors are associated with the bi-allelic APC mutation. One of the 2 known mutations
occurs distal to the second β-catenin binding/degradation repeat of the gene.
Desmoid tumors are reported to account for 0.03% of all neoplasms.1 They are twice
more common in females than in males and tend to occur in women after childbirth. In
children, the female-to-male ratio is 1:1.
Although desmoid tumors are more common in the second to ﬁfth decades of life,
they can appear in younger children and older adults.
Infantile aggressive ﬁbromatosis represents the childhood version of desmoid tumors
seen in adults.
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Figure 4. Postoperative follow-up photo at the age of 2 years. No recurrence of the tumor was
witnessed 15 months after the surgical excision. Notice the well-appearing scar in the right
nasolabial fold region.
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In the adult form, desmoid tumors most commonly develop in the anterior abdominal
wall (arising from the rectus abdominis muscle) and in the shoulder girdle but may arise in
any skeletal muscle. Retroperitoneal desmoids are common in familial Polyposis coli and
Gardner syndrome and tend to be related to abdominal surgery.
In their subcutaneous locations, desmoid tumors are ﬁrm, smooth, and mobile. They
often adhere to surrounding structures but usually spare the overlying skin. Desmoids were
reportedinintra-abdominallocationssuchastheurinarysystem.However,desmoidtumors
are extremely rare in the head and neck, especially in infants and young children.
The pathogenesis of desmoid tumors is uncertain and may be related to trauma,
hormonal factors, or mutation in the APC gene. Proliferative response of ﬁbroblasts to
estrogen was established.3
Computed tomographic (CT) scan and MRI are used for diagnosis and follow-up of
desmoid tumors. MRI is better than CT scan in deﬁning the pattern and the extent of
involvement as well as recurrence after surgery.
Histologically,desmoidtumorsarecomposedofabundantcollagensurroundingpoorly
circumscribed bundles of spindle cells. These eosinophilic spindle cells contain regular
nuclei and a pale cytoplasm. No mitoses or giant cells are present, a ﬁnding that helps
differentiate these tumors from ﬁbrosarcoma.1
Treatment of desmoid tumors consists of aggressive surgical resection with clear
surgical margins. Positive margins after surgery can be associated with a high risk of
recurrence (∼70%).2 Complete surgical excision of desmoid tumors is considered to be the
only effective method of cure.
In patients who refuse surgery or represent poor surgical candidates, the following
alternative modalities of treatment may be considered:
1. Radiation therapy can be considered for treatment of recurrent disease or as a primary
modality used to avoid a mutilating surgical resection. Radiotherapy yields local control
rates of approximately 75% to 80%.
2. Pharmacologic therapy with antiestrogen and prostaglandin inhibitors. The rationale
behind this treatment is based on the possible endocrine etiology of desmoid tumors in
whichﬁbroblastproliferationisseeninresponsetoestrogen.Thishypothesisissupported
by the fact that desmoid tumors most commonly appear in young women during or after
pregnancy; the tumors regress during menopause, after tamoxifen treatment, and after
exposure to oral contraceptives.
3. Chemotherapy(regimenofdoxorubicin,dacarbazine,andcarboplatin)isreservedmostly
for recurrent extra-abdominal desmoid tumors.
Clinical features associated with high rate of recurrence include presentation at
greater than 5 years of age, tumor location at the extremities, and an incomplete surgical
resection.
Histological features associated with high rate of recurrence include microscopic
evidence of tumor at the surgical margins, a mitotic index of 5 or more per 10 high-power
ﬁelds, and evidence of necrosis and inﬂammation within the tumor.4
Infantile aggressive ﬁbromatosis is a rare entity. It arises as a solitary mass in the
skeletal muscle, adjacent fascia, aponeurosis, or periosteum. Microscopically it can present
in2forms:thediffuse(mesenchymal)typeandthedesmoidtype.Thelesscommondesmoid
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form is rarely seen in infancy. Several case reports have described an aggressive infantile
ﬁbromatosis involving the mandible.5−12
In most of these cases, radical surgical excision of the tumor and reconstruction of
the mandible was the treatment modality, with no evidence of recurrence. However, in
some cases, conservative surgical resection of the tumor was conducted with adjuvant
chemotherapy and radiotherapy to minimize the recurrence rate and limit the surgical
mutilation.9
Other case reports described desmoid tumor in the submandibular region of a 3-year-
old girl13 and of an 18-month-old girl,14 the maxilla of a 7-year-old black Jamaican boy,15
baseofthetongue,16 theparotidglandofa7-year-oldgirl,17 thescalp,18 thenasalcavityand
paranasal sinuses in a 2-year-old boy,19 and the base of skull (resulting in a fatal outcome)
in a 10-year-old boy.20
A single-case report describing an extra-abdominal ﬁbromatosis of the cheek21 sug-
gests its exceptional location among the rare cases of desmoid tumors in the head and neck
in infants and children.
A retrospective review dealing with treatment of desmoid tumors in the head and
neck was recently published. Tostevin et al22 published data from 6 children with ag-
gressive ﬁbromatosis occurring in the head and neck. They concluded that primary ex-
cision is not always possible in this location, even though adjunctive modalities may
not be feasible in children because of high rate of complications and interference with
growth.22
The use of chemotherapy in infantile desmoid tumors was suggested in one study.
The authors treated 3 children with progressive unresectable ﬁbromatosis in unfavorable
locations with pegylated liposomal doxorubicin (ie, nasal cavity, fossa infratemporalis, oral
cavity, abdomen, and fossa supraclavicularis). Tumor response was obtained on MRI in
all patients. All children have retained a normal cardiac function after the completion of
chemotherapy as evaluated by left-ventricular shortening fraction. Severe neutropenia was
not observed.23
CONCLUSION
Desmoid tumors are benign, rare, ﬁrm ﬁbrous neoplasms arising from the muscu-
loaponeurotic structures throughout the body. These tumors are inﬁltrative and locally
aggressive and thus tend to recur but lack the potential to metastasize. The patho-
genesis of desmoid tumors is uncertain and may be related to trauma, hormonal fac-
tors, or a mutation in the APC gene. Desmoid tumors of the head and neck are
uncommon in all age populations. Infantile aggressive ﬁbromatosis is the childhood ver-
sion of ﬁbromatosis in adults. Complete surgical resection followed by radiation ther-
apy is the current standard therapy. Pharmacological treatment may be added in selected
cases.
Ourreportofaninfantwithadesmoidtumoronhercheekrepresentsanexampleofthe
desmoid type of infantile aggressive ﬁbromatosis arising in an exceedingly rare location.
Surgical excision resulted in a complete removal of the tumor without evidence of local
recurrence in 15 months’ follow-up period.
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